Kayode Abidemi John is a pharmacist and a United States-based cancer researcher whose work focuses on prostate cancer at the Graduate School of Biomedical Sciences, University of Texas Health Science ...

I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...

Ahmedabad-based Zydus Lifesciences Ltd has inked a pact with precision diagnostics company Myriad Genetics from the USA to ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Cliff Richard, 85, said in an interview with “Good Morning Britain” that he was diagnosed with prostate cancer in 2024 after ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

LONDON -- British pop star Cliff Richard said Monday he has been given the all-clear after treatment for prostate cancer. The ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...